InvestorsHub Logo

flipper44

02/07/19 10:39 AM

#213398 RE: CogDiss 1188X #213393

Instead, about 95% of all patients in the Optune trial had progressed by two years. 96% of SOC and 94% of Treatment.

survivor1x

02/07/19 10:48 AM

#213402 RE: CogDiss 1188X #213393

LOL,

"Relative Risk"

While it can be a useful measure. Everything must be taken in context. Sure 6% is 50% better than 4% (relatively) but in reality it is not much more than a rounding error in absolute terms. I mean 12 vs 10 is only a 20% difference. They could wait until it was 1% vs 3% and they would have a 200% RRR but it wouldn't be meaningful.


Wonder what the "Relative Risk" reduction of death will be in the DCVAX arm a5 5 years? 200-300%? 5 vs 15-20?